Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Human Papilloma Virus Infection, Recurrent Cervical Cancer, Stage IVA Cervical Cancer and Stage IVB Cervical Cancer Clinical Trial Using ipilimumab and laboratory biomarker analysis

- The folks at National Cancer Institute (NCI) are studying the effects of ipilimumab; laboratory biomarker analysis on Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Human Papilloma Virus Infection, Recurrent Cervical Cancer, Stage IVA Cervical Cancer and Stage IVB Cervical Cancer in females ages 18 years and older. This clinical trial is slated to start December 2012.

Overall Study Contact Info
StatusName Contact Phone
Recruiting

This study is officially titled, "A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies."

Locations

City of Hope

Duarte, California - Recruiting

University of Southern California

Los Angeles, California - Recruiting

UC Davis Comprehensive Cancer Center

Sacramento, California - Recruiting

City of Hope- South Pasadena Cancer Center

South Pasadena, California - Recruiting

University of Chicago Comprehensive Cancer Center

Chicago, Illinois - Recruiting

Fox Chase Cancer Center

Philadelphia, Pennsylvania - Recruiting

Tom Baker Cancer Centre

Calgary, Alberta - Recruiting

Cross Cancer Institute

Edmonton, Alberta - Recruiting

BCCA-Vancouver Cancer Centre

Vancouver, British Columbia - Recruiting

Juravinski Cancer Centre at Hamilton Health Sciences

Hamilton, Ontario - Recruiting

Cancer Centre of Southeastern Ontario at Kingston General Hospital

Kingston, Ontario - Recruiting

London Regional Cancer Program

London, Ontario - Recruiting

Ottawa General Hospital

Ottawa, Ontario - Recruiting

University Health Network-Princess Margaret Hospital

Toronto, Ontario - Recruiting

For more study details, please visit this link to ClinicalTrials.gov record, which is the source of this webpage.